Webinar: From Quality, Risk, and Compliance (QRC) to a Culture of Excellence
Discover your potential savings with our ROI Calculator
Self-guided Product Tours
Product Demo Videos
Pricing
Recent Analyst Insights
Featured Analyst Insights
2026 Gartner® Magic Quadrant™ for Quality Management System Software
Recent Blogs
Recent Infographics
Recent Case Studies
Featured Case Study
ComplianceQuest Medical Devices QMS Success Stories eBook
Recent Checklists
Featured Checklist
Complaint Handling Process for MedTech and Life Science Companies
Course Offerings
Recent CQ Guides
Datasheets
Brochures
Demo Center
Videos
Podcasts
Recent Webinars
Webinar
Unlocking the Value of Complaints
Recent Whitepapers
Whitepaper
Why You Need to Digitally Transform Your QMS
Compliance
Toolkits
Infographic
Safety Technology Trends to Watch in 2023 (Infographic)
Recent Toolkits
Events and Webinars
Events
Upcoming Webinars
Featured Event
Safety 2026 Anaheim, CA
15 Jun, 2026
Anaheim, CA
About
About ComplianceQuest
Transform to a fully connected business with a next-generation AI-powered Product Lifecycle, Quality, Safety, and Supplier management platform, built on Salesforce.
Our connected suite of solutions helps businesses of all sizes increase quality, safety and efficiency as they bring their products from concept to customer success.
Meet the Leadership Team
Careers
Where Your Career Takes Flight: Join our dynamic team and be part of an innovative, collaborative and rewarding workplace culture.
Corporate Citizenship
Impact Through Action: How the ComplianceQuest team supports social causes and community engagement
Customers & Testimonials
Newsroom
The Pulse of ComplianceQuest: Our newsroom shares stories of innovation, progress, and change
Partners
Stronger Together: How our partnerships drive success and innovation
Upcoming Events
Part 11 of Title 21 of the Food and Drug Administration’s Code of Federal Regulations provides guidelines to companies operating in the US to set up a digital Quality Management System. It focuses on using electronic records and e-signatures, replacing paper-based documentation and signatures.
First published in 1996, Part 11 has been evolving to keep pace with technological changes and the manufacturing processes that go into developing the products. It reduces the documentation burden on medical device manufacturers, who earlier struggled to get signatures from authorized signatories on paper documents to pass FDA audits. The later versions facilitated the use of digital tools to speed the time-to-market while ensuring appropriate authentication and control to get the necessary approvals to ensure the quality and safety of the products.
The regulation applies to any life sciences company releasing its products in the US and for any relevant documents stored on the computer system during the development, even if paper copies are available in hard copy. Pharmaceutical, biotechnology, medical device manufacturers, clinical laboratories, developers, manufacturers, testers, or distributors of FDA-regulated products can benefit.
21 CFR Part 11 is categorized into subparts A, B, and C based on the three primary areas it applies to:
Subpart A—General Provisions: This section defines the scope and applicability of the clause, providing key definitions for the terms used in the regulation.
Subpart B – Electronic Records: It delineates the requirements for creating, modifying, and maintaining electronic records, with controls and procedures to ensure the data is secure, audit trails have been implemented, and system access is limited as per authorization needs.
Subpart C—Electronic Signatures: This part is focused on the use of electronic signatures and outlining their proper use, including implementing controls for identification codes and passwords.
21 CFR Part 11 addresses not only text-based documents but also graphics, data, audio, pictorial, or other information created, modified, maintained, archived, retrieved, or distributed by a computer system as per 21 CFR 11.3(b)(6).
Implementing Part 11 will improve the medical device manufacturer’s efficiency and aid in developing a compliant and paperless QMS. This will streamline processes, minimize delays, and ensure the delivery of safer and high-quality products.
Some of the benefits of 21 CFR Part 11 for medical device manufacturers include:
Part 11 imitates the stringent conformance to legally binding requirements when allowing e-signatures in electronic documents. The document must contain the following information:
In addition to the three requirements, it also stresses authenticating the identity of the signee to prevent falsification.
A cloud-based quality management system such as ComplianceQuest facilitates the creation, maintenance, and secure access of electronic records in life sciences companies. ISO-compliant, it is already aligned with FDA requirements and helps manufacturers streamline their workflows around electronic document lifecycles.
Part 11 allows manufacturers to opt between a closed system, which requires authorization to access the records, or open systems with specific requirements with limited access to particular documents to authorized users. ComplianceQuest facilitates the creation and sharing of Standard Operating Procedures (SOPs) and training documents around Part 11 to improve the accountability of the individuals handling the electronic system.
The system enables the validation of the records system, ensuring it is secure and reliable. You can also use the system to create certified copies, maintain audit trails, and archive records.
It enables collaboration between remote teams and staff for quick reviews and approvals, also providing an audit trail for transparency and visibility. When the required storage period is over and the document becomes obsolete, the system creates notifications for the next best action based on regulatory requirements.
To learn more about the ComplianceQuest Quality Management System, visit www.compliancequest.com.
Please confirm your details
By submitting this form you agree that we can store and process your personal data as per our Privacy Statement. We will never sell your personal information to any third party.
Enter Captcha